Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INTUITIVE SURGICAL, INC.

(ISRG)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 01/28 11:00:18 am
262.85 USD   +0.03%
01/26INSIDER SELL : Intuitive Surgical
MT
01/26NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
01/25Intuitive Surgical Shares Fall After Redburn Downgrade
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Intuitive Announces Executive Leadership Changes

11/22/2021 | 04:37am EST

SUNNYVALE, Calif. - Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced executive leadership changes that reflect the company's growth and plans for advancing minimally invasive care globally.

Intuitive has created two new functional organizations: Strategy and Growth, and Global Business Services. These organizations will be led by experienced senior executives who have spent decades with Intuitive. Placing strategy and growth teams within a new organization will create clearer prioritization and stronger alignment for investments in support of the company's long-term growth plan. Given the opportunities for continued growth, the new global business services organization will serve to align and scale processes, manage multi-year IT roadmaps, better use enterprise data for real-time decision-making, and maintain and execute global facilities and maintenance roadmaps.

The following executives will begin their duties on Jan. 1, 2022:

Marshall Mohr will assume the new role of Executive Vice President, Global Business Services, where he will lead Intuitive's continued growth in infrastructure, processes, and systems and facilities. He has served as Chief Financial Officer for more than 15 years.

Jamie Samath will succeed Mohr to become Chief Financial Officer, focusing on Intuitive's financial performance, growth objectives, and future fiscal trajectory. Samath has been with Intuitive since 2013, managing most of the finance functions during that time.

Dave Rosa will assume the new role of Executive Vice President and Chief Strategy & Growth Officer, leading efforts to identify and realize long-term business opportunities, continuing to build the value of Intuitive's product offerings, and ensuring customers clearly understand the value of Intuitive's ecosystem in creating successful minimally invasive care programs. Rosa has been with Intuitive for more than 25 years, working across the business.

Henry Charlton will succeed Rosa in the role of Chief Commercial Officer, overseeing global sales, regional marketing, commercial learning and enablement, and services. He has been with Intuitive for 18 years in the commercial organization.

'These are outstanding and proven leaders. I am confident they will be effective in pursuing our goal to advance minimally invasive care globally in a highly competitive environment,' said Intuitive CEO Gary Guthart. 'Their efforts will help us operate at the larger scale our customers demand globally.'

With strong leadership in new and existing roles, Intuitive will continue to drive measurable improvement in the Quadruple Aim for customers-better patient outcomes, better patient and care team experiences, and lower total cost to treat-and meet the future challenges of healthcare.

Intuitive pioneered the field of robotic-assisted minimally invasive surgery more than two decades ago with the da Vinci surgical system. Since then, more than 8.5 million procedures have been performed using da Vinci systems, with more than 55,000 surgeons worldwide trained on da Vinci systems.

About Intuitive

Intuitive (Nasdaq: ISRG), headquartered in Sunnyvale, Calif., is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. As part of our mission, we believe that minimally invasive care is life-enhancing care. Through ingenuity and intelligent technology, we expand the potential of physicians to heal without constraints.

Intuitive brings more than two decades of leadership in robotic-assisted surgical technology and solutions to its offerings, and develops, manufactures, and markets the da Vinci surgical system and the Ion endoluminal system (available only in the U.S.).

About the da Vinci Surgical System

There are several models of the da Vinci surgical system. The da Vinci surgical systems are designed to help surgeons perform minimally invasive surgery. Da Vinci systems offer surgeons high-definition 3D vision, a magnified view, and robotic and computer assistance. They use specialized instrumentation, including a miniaturized surgical camera and wristed instruments (i.e., scissors, scalpels and forceps) that are designed to help with precise dissection and reconstruction deep inside the body.

About Ion

Ion is Intuitive's robotic-assisted platform for minimally invasive biopsy in the lung. The system features an ultra-thin, ultra-maneuverable catheter that allows navigation far into the peripheral lung and provides the unprecedented stability necessary for precision in biopsy.

Forward-Looking Statements

This press release contains forward-looking statements, including statements regarding executive leadership changes. These forward-looking statements include statements regarding our future operational and financial performance, product development, market position and business strategy. These statements reflect the best judgment of the Company's management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements. These forward-looking statements should, therefore, be considered in light of the risk factors under the heading 'Risk Factors' in our report on Form 10-K for the year ended December 31, 2020, as updated by the Company's other filings with the Securities and Exchange Commission. Statements using words such as 'estimates,' 'projects,' 'believes,' 'anticipates,' 'plans,' 'expects,' 'intends,' 'may,' 'will,' 'could,' 'should,' 'would,' 'targeted,' and similar words and expressions are intended to identify forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update or release any revisions to these forward-looking statements, except as required by law.

Contact:

US/GLOBAL

Global Public Affairs

Intuitive Surgical

E: corp.comm@intusurg.com

T: +1-202-997-7373

(C) 2021 Electronic News Publishing, source ENP Newswire

All news about INTUITIVE SURGICAL, INC.
01/26INSIDER SELL : Intuitive Surgical
MT
01/26NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
01/25Intuitive Surgical Shares Fall After Redburn Downgrade
MT
01/25Redburn Downgrades Intuitive Surgical to Neutral from Buy
MT
01/24Argus Adjusts Intuitive Surgical's Price Target to $330 From $380, Maintains Buy Rating
MT
01/24NORTH AMERICAN MORNING BRIEFING : Stocks Seen -3-
DJ
01/21AFTER HOURS WATCH LIST SCORECARD : Vmac, isrg, nflx
MT
01/21UBS Adjusts Intuitive Surgical Price Target to $317 From $338, Maintains Neutral Rating
MT
01/21Intuitive Surgical Down Nearly 7%, on Pace for Largest Percent Decrease Since April 202..
DJ
01/21BTIG Adjusts Intuitive Surgical's Price Target to $360 From $372; Buy Rating Kept
MT
More news
Analyst Recommendations on INTUITIVE SURGICAL, INC.
More recommendations
Financials (USD)
Sales 2021 5 721 M - -
Net income 2021 1 668 M - -
Net cash 2021 2 405 M - -
P/E ratio 2021 58,9x
Yield 2021 -
Capitalization 93 871 M 93 871 M -
EV / Sales 2021 16,0x
EV / Sales 2022 14,3x
Nbr of Employees 8 081
Free-Float 99,1%
Chart INTUITIVE SURGICAL, INC.
Duration : Period :
Intuitive Surgical, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INTUITIVE SURGICAL, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 262,77 $
Average target price 327,38 $
Spread / Average Target 24,6%
EPS Revisions
Managers and Directors
Gary S. Guthart Chief Executive Officer & Director
Jamie E. Samath Chief Financial Officer
Craig H. Barratt Chairman
Myriam J. Curet Chief Medical Officer & Executive Vice President
Kara Andersen Reiter Assistant General Counsel
Sector and Competitors